Newsfile Corp
10 Oct 2026, 16:23 UTC · 1h ago
AARD DEADLINE TUESDAY: ROSEN, A LONGSTANDING LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD
Impact · against what's priced in
The announcement of a lead plaintiff deadline for Aardvark Therapeutics increases the risk of institutional litigation regarding the safety of ARD-101. For J.B. Hunt, the mention of a securities class action investigation is not material to the specific operational and growth drivers currently pricing the stock.
- JBHT+0.00
Doesn't touch the price's assumptions
- In context





